Arcadia Biosciences (RKDA) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to 0.63.
- Arcadia Biosciences' Equity Ratio fell 605.51% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year decrease of 605.51%. This contributed to the annual value of 0.46 for FY2024, which is 2935.25% down from last year.
- Per Arcadia Biosciences' latest filing, its Equity Ratio stood at 0.63 for Q3 2025, which was down 605.51% from 0.58 recorded in Q2 2025.
- Over the past 5 years, Arcadia Biosciences' Equity Ratio peaked at 0.78 during Q1 2022, and registered a low of 0.46 during Q4 2024.
- For the 5-year period, Arcadia Biosciences' Equity Ratio averaged around 0.66, with its median value being 0.67 (2023).
- Per our database at Business Quant, Arcadia Biosciences' Equity Ratio skyrocketed by 9168.97% in 2021 and then plummeted by 2935.25% in 2024.
- Over the past 5 years, Arcadia Biosciences' Equity Ratio (Quarter) stood at 0.71 in 2021, then grew by 2.38% to 0.73 in 2022, then decreased by 10.39% to 0.65 in 2023, then decreased by 29.35% to 0.46 in 2024, then soared by 37.73% to 0.63 in 2025.
- Its Equity Ratio stands at 0.63 for Q3 2025, versus 0.58 for Q2 2025 and 0.69 for Q1 2025.